European and Spanish statistics indicate this 80% of women experience symptoms associated with menopause. the Choking and night sweats It is one of the most common conditions, as up to eight women out of ten suffer from it, especially in the first two years after the last menstrual period. One of these 10% Indicates that these symptoms They interfere in daily lifeBut as a rule, the majority They do not take any treatment.
In this context, one of them arrived in Spain New medicinethe first No hormonalintended for Reduce symptoms Vasodilators associated with menopause. The main novelty is that it provides an alternative for those women “who do not want or cannot use hormonal treatments,” according to the doctor. Maria Vaserogynecologist at La Zarzuela University Hospital and official spokespersonSpanish Association for the Study of Menopause (AEEM).
In 2002, I published an article related to Hormonal treatments to increase breast cancer Since then, these drugs have made women and many health professionals reluctant to take them. For this reason, non-hormonal medication can offer an alternative and pave the way for menopause to receive acceptable and appropriate treatment.
Balance
Symptoms of menopause arise inHypothalamusIt is the part of the brain responsible for regulating body temperature through nails Neurons are called KNDy. Under normal circumstances, there is a balance betweenEstrogenwhich inhibits these nerve cells, and the brain substance, the Neurokinina B (NKB), which motivates them. During menopause, when estrogen levels decrease, this balance is lost, causing an imbalance in the hypothalamus. Interpretation: The body is hot While in reality it does not contain anything and causes sweating and blatant suffocation.
The new drug is marketed under the name: Fyoza, contains Visolent, It is an orally administered neurokinin 3 (NK3) receptor antagonist that works by blocking the binding of neurokinin B to KNDy neurons. In this way it helps restore thermal balance, Reducing the frequency and severity of hot flashes and night sweats.
Results
to’Efficacy and safety Visolent has been tested in Three clinical trials in which they participated 3000 women. The result showed that this medication reduces hot flashes and moderate to severe sweating from the first week of taking it.
“Moderate to severe choking can significantly impact the quality of life of menopausal women. Moderate to severe choking are those that lead to cessation of normal activity. Both can affect mood, personal relationships and work life.” Focus, social activities, and even personal care.” Santiago Palaciosgynecologist and director of the Palaus Institute of Women’s Health and Medicine.
“Infuriatingly humble social media buff. Twitter advocate. Writer. Internet nerd.”
